Company: NIVFW
Filing Date: 2025-09-18
Form Type: F-1
Source: 0001213900-25-088927
Chunk: 6

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-18
Form: F-1
Chunk 6
---
 |   68 |
| Management’s Discussion and Analysis of Financial Condition and Results of Operations |   69 |
| Business                                                                              |   85 |
| Principal Shareholders                                                                |  102 |
| Plan of Distribution                                                                  |  103 |
| Description of Share Capital                                                          |  105 |
| Taxation                                                                              |  108 |
| Legal Matters                                                                         |  114 |
| Experts                                                                               |  114 |
| Expenses                                                                              |  114 |
| Enforceability of Civil Liabilities                                                   |  115 |
| Where You Can Find Additional Information                                             |  116 |

<div align='center'>i</div>

You should rely only on the information contained in this prospectus and any free writing prospectus prepared by or on behalf of us or to which we have referred you. Neither we nor the placement agent have authorized anyone to provide you with different information. Neither we nor the placement agent are making an offer of these securities in any jurisdiction where the offer is not permitted. You should not assume that the information in this prospectus or any applicable prospectus supplement is accurate as of any date other than the date of the applicable document. Since the date of this prospectus, our business, financial condition, results of operations and prospects may have changed.

For investors outside of the
United States: Neither we nor the placement agent have done anything that would permit this offering or possession or distribution of
this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform
yourselves about and to observe any restrictions relating to this offering and the distribution of this prospectus.

In this prospectus, “we,”
“us,” “our” and the “Company” refer to NewGenIvf Group Limited and its wholly owned subsidiary, NewGenIvf
Limited, a Cayman Islands company.

Our reporting currency is
the U.S. dollar. Unless otherwise expressly stated or the context otherwise requires, references in this prospectus to “dollars”
or “$” are to U.S. dollars.

This prospectus includes statistical,
market and industry data and forecasts which we obtained from publicly available information and independent industry publications and
reports that we believe to be reliable sources. These publicly available industry publications and reports generally state that they obtain
their information from sources that they believe to be reliable, but they do not guarantee the accuracy or completeness of the information.
Although we believe that these sources are reliable, we have not independently verified the information